Company: LIMN
Filing Date: 2025-01-16
Form Type: POS AM
Source: 0001104659-25-003835
Chunk: 93

Company: Liminatus Pharma, Inc.
Filing Date: 2025-01-16
Form: POS AM
Chunk 93
---
:|:--|:--|:--|:-----------------------|:--|------------:|:--|:--|:--|:------------------------|:--|------------:|:--|:--|
| Balance Sheet Data:                                | ​ | ​ | ​                      | ​ |           ​ | ​ | ​ | ​ | ​                      | ​ |           ​ | ​ | ​ | ​ | ​                       | ​ |           ​ | ​ | ​ |
| Total cash                                         | ​ | ​ | ​                      | $ |     156,425 | ​ | ​ | ​ | ​                      | $ |     280,640 | ​ | ​ | ​ | ​                       | $ |  358,181(1) | ​ | ​ |
| Total assets                                       | ​ | ​ | ​                      | ​ |   4,502,213 | ​ | ​ | ​ | ​                      | ​ |  15,488,270 | ​ | ​ | ​ | ​                       | ​ |   3,068,186 | ​ | ​ |
| Total liabilities                                  | ​ | ​ | ​                      | ​ |  15,194,997 | ​ | ​ | ​ | ​                      | ​ |  14,194,064 | ​ | ​ | ​ | ​                       | ​ |  17,323,184 | ​ | ​ |
| Class A Common Stock subject to possibleredemption | ​ | ​ | ​                      | ​ |   4,049,650 | ​ | ​ | ​ | ​                      | ​ |  15,127,621 | ​ | ​ | ​ | ​                       | ​ |   2,452,163 | ​ | ​ |
| Total stockholders’ deficit                        | ​ | ​ | ​                      | $ | -14,742,434 | ​ | ​ | ​ | ​                      | $ | -13,833,415 | ​ | ​ | ​ | ​                       | $ | -16,707,161 | ​ | ​ |

(1) As of September 30, 2024 and December 31, 2023, $32,580 of the $358,181 and $85,084 of the $156,425, respectively of the cash balances include restricted cash to be used for tax payments only.

24

TABLE OF CONTENTS

SUMMARY UNAUDITED PRO FORMA COMBINED FINANCIAL INFORMATION The following summary unaudited pro forma combined